ABAdrianus J. Bakermans

Adrianus J. Bakermans

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adrianus J. Bakermans has a total of 145 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acute effects of marathon running on the heart: a systematic review and meta-analysis

    by Inarota Laily, Niels van Steijn, Putra Rizki, Ralph de Vries, Lies D Liastuti, Aeilko H Zwinderman, Evert Verhagen, Adrianus J Bakermans, Harald T Jorstad

    Background: Marathon running has numerous cardiovascular effects. Studies report transient physiological changes, while others identify possible harmful cardiovascular changes. This systematic review and meta-analysis aimed to characterise acute cardiac effects of marathon running. Methods: A systematic search was conducted in PubMed, Embase, and SPORTDiscus up to 11 April 2025. Studies were included if they reported (i) primary data (ii) in English (iii) healthy adults completing a road marathon, (iv) quantitative pre- and post-marathon cardiac effects. After data extraction (myocardial biomarkers, morphology, and function), random-effect meta-analyses were performed to determine mean differences and relative changes between pre- and post-marathon. Meta-regression analyses were performed in metrics with ≥7 studies. Results: Of 9080 articles, 69 were eligible for systematic review (3274 participants: age 30–55 years, >80% men) and 49 for meta-analysis on three biomarkers, 18 echocardiography metrics, and five cardiac MRI metrics. Marathon running-induced increases in circulating troponin T (+42 (32.6, 52.3) ng/L; p<0.001), troponin I (+77 (55.1, 98.3) ng/L; p<0.001) and N-terminal pro B-type natriuretic peptide (NT-proBNP) (+114 (89.0, 138.6) ng/L; p<0.001). On echocardiography, left ventricular (LV) volume and diastolic function, and right ventricular (RV) systolic function decreased post-marathon, while RV end-systolic and diastolic volumes increased. Cardiac MRI revealed an increase in LV ejection fraction. On meta-regression analysis, these responses varied according to age, sex, training status and marathon performance. Conclusion: Marathon running induces acute changes in biomarkers of myocardial injury, cardiac structure and function. The clinical significance and potential for harm of these changes are yet to be established. PROSPERO registration number: CRD42023399120

  • Open Access

    Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomized clinical trial

    by Arno A van de Bovenkamp, Soufiane Nassiri, Frances S de Man, Frank P T Oosterveer, Sanne G J Mourmans, Daniël H van Raalte, Pieter A Dijkmans, Loek van Heerebeek, Vanessa P M van Empel, Etto C Eringa, et al.

    Aims: Iron deficiency (ID) is common in patients with heart failure with preserved ejection fraction (HFpEF). The IRON-HFpEF trial aimed to evaluate the mechanistic effects of intravenous iron supplementation on cardiovascular function and exercise tolerance in HFpEF. Methods: 45 patients with HFpEF (LV ejection fraction ≥50%) and ID were recruited from Amsterdam UMC and Maastricht UMC+. Patients with ID-anaemia were excluded. Patients were randomized to receive either ferric carboxymaltose (FCM) or placebo. At baseline and 4 months, assessments included exercise right heart catheterization, 6-minute walking distance (6MWD), cardiac MRI, exercise calf muscle 31P-magnetic resonance spectroscopy, and laser speckle contrast analysis. There was also an open-label extension. Results: Patients were in functional class II-III. FCM had no effect on pulmonary capillary wedge pressure during multiple levels of exercise (mean change −1.0 mmHg, 95% CI [−4, 2]; P = .52). FCM did not change myocardial PCr/ATP ratio (P = .18), calf muscle PCr recovery time (P = .11), NT-proBNP (P = .78), or Kansas City Cardiomyopathy Questionnaires (P = .67). However, FCM led to an improvement in right ventricular ejection fraction (FCM: +4 ± 5% vs placebo: −3 ± 6%; P = .002) and acetylcholine-mediated microvascular perfusion (FCM: +5 ± 24 vs placebo: −16 ± 25 a.u.; P = .04), and seemed to marginally improve 6MWD (+6 ± 31 m vs −13 ± 31 m; P = .06). After correction for baseline differences, FCM improved 6MWD (+28 m; P = .01). Conclusion: In patients with HFpEF and ID without ID-anaemia, FCM did not improve exercise hemodynamics, LV diastolic function, myocardial or skeletal energy homeostasis. Exploratory analyses suggest that FCM does improve exercise tolerance (6MWD), potentially through improvement of microvascular endothelial function and RV function.


  • Open Access

    31 P‐MRS of the Human Heart at 7 T With an Integrated Whole‐Body 31 P Radiofrequency Transmit Coil

    by Mark W. J. M. Gosselink, Martijn Froeling, Kathy Verkerk, Dennis W. J. Klomp, Adrianus J. Bakermans, Jeanine J. Prompers

    Phosphorus‐31 magnetic resonance spectroscopy ( 31 P‐MRS) can be used to characterize the steady‐state in vivo myocardial energy status via the phosphocreatine (PCr) over adenosine triphosphate (ATP) tissue concentration ratio. Although used in many studies, this modality suffers from low sensitivity and poor measurement precision. This work reports on the acquisition of 31 P‐MR spectra of the in vivo human heart using a 7 T MR system equipped with an integrated whole‐body RF transmit coil for 31 P spin excitation. Eight volunteers (male/female, n = 4/4) underwent 31 P‐MRS at 7 T twice, using a low‐flip angle, short‐repetition time 3D 31 P‐MR spectroscopic imaging sequence with a 20‐mm isotropic resolution and a 21‐min acquisition time. A 16‐channel 31 P receive array was used for signal reception. Myocardial voxels were identified on transversal cine proton MR images. Signals of PCr, phosphodiesters (PDE), and inorganic phosphate (P i ) were quantified relative to ATP and corrected for partial saturation and blood signal contamination. Bland–Altman analyses were used to establish intersession measurement repeatability. A comparison of supine and prone positioning was made for two subjects, yielding similar results but superior comfort for lying supine. Mid‐septal myocardial PCr/ATP was 1.85 ± 0.37, with a repeatability coefficient of 17.7%. The repeatability coefficients for P i /ATP and PDE/ATP were 142.7% and 51.6%, respectively. Using the spatially homogeneous 31 P spin excitation with the integrated whole‐body RF transmit coil, we made quantitative estimates of the myocardial energy status at a higher precision than previously achieved at lower main magnetic field strengths. The noninvasive nature and high precision of the presented 31 P‐MR spectroscopic imaging approach will allow for therapeutic efficacy monitoring with repeated measurements in longitudinal study designs and investigations of normal physiology in healthy volunteers.


  • Open Access

    Exercise MRI stress testing of the human heart at 3 Tesla: measurement precision of biventricular function and aortic blood flow during steady-state bicycling exercise

    by Hugo Klarenberg, Martijn Froeling, Tim Leiner, Hildo J. Lamb, S. Matthijs Boekholdt, Harald T. Jørstad, Gustav J. Strijkers, Adrianus J. Bakermans

    Objective: This work aimed to demonstrate the feasibility of quantifying heart function during bicycling exercise with dynamic real-time cine MRI at 3 Tesla, and to assess its measurement precision. Materials and methods: Twelve volunteers performed steady-state bicycling exercise, while real-time cine MR images were collected using a 72-channel receiver coil array and a parallel imaging acceleration factor of 5. Biventricular end-diastolic and end-systolic (ESV) volumes and function during exercise were compared with resting-state real-time cine MRI and conventional cardiac-gated cine MRI under breath holding, and validated against 2D phase-contrast MRI-based estimates of aortic blood flow. Precision was evaluated as the inter-session measurement repeatability. Results: Left (LV) and right ventricular (RV) stroke volumes (SV) increased progressively with exercise intensity, which was mediated by a decrease in ESV. Likewise, LV SV estimated with 2D phase-contrast MRI increased from 90 ± 17 mL at rest to 114 ± 29 mL during vigorous-intensity exercise. Repeatability coefficients were 52% and 41% for LV SV at moderate- and vigorous-intensity exercise, while RV SV repeatability coefficients were 58% and 42%, respectively. Discussion: We established an exercise MRI stress testing protocol for quantifying biventricular volumes and function during moderate- and vigorous-intensity steady-state bicycling exercise.

  • Open Access

    Acute impact of first-time marathon running on the heart in middle-aged men

    by Inarota Laily, Niels van Steijn, Tom G H Wiggers, Martijn Froeling, R Nils Planken, Sjoerd M Verwijs, Ferdinand H de Haan, Ehsan Motazedi, Evert A L M Verhagen, Harald T Jørstad, et al.

    Background: Middle-aged men seem to be particularly susceptible to adverse cardiovascular effects of endurance exercise. The acute impact of training, marathon finishing and recovery on the heart has not been extensively investigated in such at-risk novice marathon runners. Methods: We prospectively quantified cardiac changes in middle-aged men (41.2±4.5 years; n=17) who participated in their first marathon run at four time points: at baseline, after 16 weeks of training, within 10 hours after completing the 2021 Amsterdam Marathon run and after 4 weeks of recovery. Measurements included comprehensive 3-Tesla MRI examination, echocardiography, ECG and blood sample assays of high-sensitivity troponin-T (hs-TnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). Results: Acute effects associated with finishing the marathon run were a <10% reduction in left ventricular end-diastolic volume in absence of other morphological changes, and only minor changes in systolic contractile mechanics and diastolic filling patterns. Neither quantitative myocardial mapping with MRI nor late gadolinium enhancement revealed any signs of post-marathon myocardial injury. ECGs did not reveal any abnormalities. Circulating levels of hs-TnT and NT-proBNP had increased markedly after the marathon, with hs-TnT exceeding the clinical upper reference limit for all participants. All observed marathon running-induced effects were transient. Conclusions: Extensive phenotyping using state-of-the-art quantitative imaging modalities paired with physical assessments and blood assays in this selected cohort offers no evidence to support the notion that first-time marathon running in healthy middle-aged men has a detrimental impact on the heart.


  • Open Access

    Long-term hemodynamic responses and reverse remodeling after pharmacotherapy in HFpEF versus HFrEF: a systematic review and meta-analysis

    by Arno A. van de Bovenkamp, Soufiane Nassiri, Adrianus J. Bakermans, George L. Burchell, Frances S. de Man, Ramon B. van Loon, M. Louis Handoko

    In contrast to acute responses, long-term treatment exerted little long-term afterload reduction and stroke volume augmentation in both HFpEF and HFrEF. Reverse remodeling was clearly present in HFrEF but was hardly observed in HFpEF. These results suggest a lesser importance of any increase in stroke volume (due afterload reduction) compared with reverse remodeling in the long-term effects of heart failure medication.


  • Exercise MR of Skeletal Muscles, the Heart, and the Brain

    by Melissa T. Hooijmans, Jeroen A.L. Jeneson, Harald T. Jørstad, Adrianus J. Bakermans

  • Open Access

    Exercise MR of Skeletal Muscles, the Heart, and the Brain

    by Melissa T. Hooijmans, Jeroen A.L. Jeneson, Harald T. Jørstad, Adrianus J. Bakermans

    Magnetic resonance (MR) imaging (MRI) is routinely used to evaluate organ morphology and pathology in the human body at rest or in combination with pharmacological stress as an exercise surrogate. With MR during actual physical exercise, we can assess functional characteristics of tissues and organs under real‐life stress conditions. This is particularly relevant in patients with limited exercise capacity or exercise intolerance, and where complaints typically present only during physical activity, such as in neuromuscular disorders, inherited metabolic diseases, and heart failure. This review describes practical and physiological aspects of exercise MR of skeletal muscles, the heart, and the brain. The acute effects of physical exercise on these organs are addressed in the light of various dynamic quantitative MR readouts, including phosphorus‐31 MR spectroscopy (31P‐MRS) of tissue energy metabolism, phase‐contrast MRI of blood flow and muscle contraction, real‐time cine MRI of cardiac performance, and arterial spin labeling MRI of muscle and brain perfusion. Exercise MR will help advancing our understanding of underlying mechanisms that contribute to exercise intolerance, which often proceed structural and anatomical changes in disease. Its potential to detect disease‐driven alterations in organ function, perfusion, and metabolism under physiological stress renders exercise MR stress testing a powerful noninvasive imaging modality to aid in disease diagnosis and risk stratification. Although not yet integrated in most clinical workflows, and while some applications still require thorough validation, exercise MR has established itself as a comprehensive and versatile modality for characterizing physiology in health and disease in a noninvasive and quantitative way.Evidence Level: 5Technical Efficacy: Stage 1


  • Open Access

    The hemodynamic cardiac profiler volume-time curves and related parameters: an MRI validation study

    by Maurits K Konings, Manuella Al Sharkawy, Sjoerd M Verwijs, Adrianus J Bakermans, Martijn Visscher, Charles L Hollenkamp, Denise P Veelo, Harald T Jørstad

    Background. The hemodynamic cardiac profiler (HCP) is a new, non-invasive, operator-independent screening tool that uses six independent electrode pairs on the frontal thoracic skin, and a low-intensity, patient-safe, high-frequency applied alternating current to measure ventricular volume dynamics during the cardiac cycle for producing ventricular volume-time curves (VTCs). Objective. To validate VTCs from HCP against VTCs from MRI in healthy volunteers. Approach. Left- and right-ventricular VTCs were obtained by HCP and MRI in six healthy participants in supine position. Since HCP is not compatible with MRI, HCP measurements were performed within 20 min before and immediately after MRI, without intermittent fluid intake or release by participants. Intraclass correlation coefficients (ICCs) were calculated to validate HCP-VTC against MRI-VTC and to assess repeatability of HCP measurements before and after MRI. Bland–Altman plots were used to assess agreement between relevant HCP- and MRI-VTC-derived parameters. Precision of HCP’s measurement of VTC-derived parameters was determined for each study participant by calculating the coefficients of variation and repeatability coefficients. Main results. Left- and right-ventricular VTC ICCs between HCP and MRI were >0.8 for all study participants, indicating excellent agreement between HCP-VTCs and MRI-VTCs. Mean (range) ICC of HCP right-ventricular VTC versus MRI right-ventricular VTC was 0.94 (0.88–0.99) and seemed to be slightly higher than the mean ICC of HCP left-ventricular VTC versus MRI-VTC (0.91 (0.80–0.96)). The repeatability coefficient for HCP’s measurement of systolic time (tSys) was 45.0 ms at a mean value of 282.9 ± 26.3 ms. Repeatability of biventricular HCP-VTCs was excellent (ICC 0.96 (0.907–0.995)). Significance. Ventricular volume dynamics measured by HCP-VTCs show excellent agreement with VTCs measured by MRI. Since abnormal tSys is a sign of numerous cardiac diseases, the HCP may potentially be used as a diagnostic screening tool.